New Study Positions Nevisense's EIS as a Valuable and Sensitive Tool for Assessing Skin Barrier Impairment

PR NewswireMar 10 08:27 ET

New Publication: US Clinicians' Real-world Nevisense Experience Improves Melanoma Detection

PR NewswireMar 5 02:24 ET

SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion

MT NewswiresMar 2 04:19 ET

Express News | SCIB Reports FY25QOther Revenue of RM54 Million

Moomoo NewsFeb 26 05:45 ET

SCIB: Consolidated results for the financial period ended 31/12/2025

Bursa MalaysiaFeb 26 05:42 ET · Announcements

SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma Which Supports the Use of EIS in the Detection of Melanoma

PR NewswireFeb 19 08:14 ET